OliX Pharmaceuticals, Inc (KOSDAQ:226950)
77,300
-5,100 (-6.19%)
Nov 20, 2026, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 1.76 trillion as of November 20, 2026. It is the 8,138th most valuable company in the world and the 196th biggest in South Korea. Its market cap has decreased by 34.56% in one year.
Market Cap
1.76T
Enterprise Value
1.57T
Revenue
13.64B
Global Rank
Country Rank
#196 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 1.76T, an increase of 316.71%. That is a compound annual growth rate of 18.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.76T | -37.96% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 3.60T |
| SK bioscience | 3.00T |
| Hugel | 2.27T |
| Peptron | 2.01T |
| ABL Bio | 1.97T |
| LigaChem Biosciences | 1.92T |
| Voronoi | 1.91T |
| D&D Pharmatech | 1.55T |